ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 23-25, 2018 in Orlando, FL.
InSphero Partners with ALPCO to Advance Diabetes Research
InSphero extends 3D InSight™ Diabetes Discovery Platform to include ALPCO STELLUX® Chemiluminescent ELISA technology for assessment of pancreatic β-cell function.
Dorothy Hodgkin’s Discovery of Insulin’s 3D Structure
Celebrate International Women's Day 2018 by learning about Dorothy Hodgkin's discovery of insulin's 3D structure.
Researchers Offer Inspiration and Advice for World Diabetes Day
In recognition of the World Diabetes Day 2017 theme: "Women and Diabetes", we asked researchers Dr. Darleen Sandoval, Dr. Lori Sussel, and Dr. Christine Doucette to share their career inspiration and advice for aspiring investigators.
ALPCO to Highlight Assay Qualification Program at AACC’s 69th Annual Clinical Lab Expo
Visit us at AACC's 69th Annual Clinical Lab Expo to learn about a variety of products supported by our assay qualification program.